Bradley, M., Markesbery, W., & Lovell, M. (2010). Increased levels of 4-hydroxynonenal and acrolein in the brain in preclinical Alzheimer disease. Free Radical Biology & Medicine, 48(12), 1570-6. https://doi.org/10.1016/j.freeradbiomed.2010.02.016 (Original work published 2010)

Lovell, M. (2011). Memories of Dr. William R. Markesbery. Neuromolecular Medicine, 13(1), 15-6. https://doi.org/10.1007/s12017-010-8117-7

Bradley, M., Xiong-Fister, S., Markesbery, W., & Lovell, M. (2012). Elevated 4-hydroxyhexenal in Alzheimer’s disease (AD) progression. Neurobiology of Aging, 33(6), 1034-44. https://doi.org/10.1016/j.neurobiolaging.2010.08.016

Lovell, M., Soman, S., & Bradley, M. (2011). Oxidatively modified nucleic acids in preclinical Alzheimer’s disease (PCAD) brain. Mechanisms of Ageing and Development, 132(8-9), 443-8. https://doi.org/10.1016/j.mad.2011.08.003

Weidner, A., Bradley, M., Beckett, T., Niedowicz, D., Dowling, A., Matveev, S., … Murphy, M. RNA oxidation adducts 8-OHG and 8-OHA change with Aβ42 levels in late-stage Alzheimer’s disease. PloS One, 6(9), e24930. https://doi.org/10.1371/journal.pone.0024930 (Original work published 2011)

Schmitt, F., Nelson, P., Abner, E., Scheff, S., Jicha, G., Smith, C., … Kryscio, R. (2012). University of Kentucky Sanders-Brown healthy brain aging volunteers: donor characteristics, procedures and neuropathology. Current Alzheimer Research, 9(6), 724-33. https://doi.org/10.2174/156720512801322591